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Abstract
OBJECTIVE:Moxibustion has long been thought to
promote vital energy or immunity through clinical
experience. This study aimed to investigate the clini-
cal effects of indirect moxibustion on antioxidant
and immunomodulation in a normal population.
METHODS: Twenty-five healthy volunteers with no
objective or subjective disorders were recruited.
The participants were treated with indirect moxi-
bustion on acupoints Guanyuan (CV 4) and
Shenque (CV 8 ) three times per week for 4 weeks.
The serum levels of reactive oxygen species (ROS)
and malondialdehyde (MDA), the total antioxidant
capacity (TAC), the activities of catalase and super-
oxide dismutase (SOD), and the total glutathione
content were determined before and after the 12th
moxibustion. Lymphocyte subpopulations and 42
cytokines in the peripheral blood were analyzed us-
ing flowcytometryandantibodyarray, respectively.
RESULTS: Compared with the initial time point, the
serum levels of ROS and MDA were significantly
lowered by moxibustion, while TAC was increased
(P<0.01 for all). A significant increase was observed
in catalase activity (P<0.05), but not in SOD or total
glutathione. There were no significant changes in
lymphocyte subpopulations or cytokines in the pe-
ripheral blood. Fifteen of 25 participants reported
at least one symptom in which they felt subjective
improvement after moxibustion.
CONCLUSION: Indirect moxibustion on acupoints
CV 4 and CV 8 improved the antioxidant defense
system, which may be a mechanism explaining the
clinical effects of moxibustion.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Moxibustion, one of the main therapies in traditional
Oriental medicine, involves the creation of thermal
and chemical stimulants by burning moxa on certain
acupoints of the body.1 Moxibustion has been prac-
ticed especially to treat chronic illness conditions and
prevent disease because it has long been thought to pro-
mote vital energy and immune function through clini-
cal experience.2,3
Many recent studies have proven the scientific evidence
supporting the efficacy of moxibustion for diverse dis-
orders such as stroke sequelae, ulcerative colitis, and
menopausal hot flashes.4-7 A few studies elucidated the
mechanisms of moxibustion in human and animal
models. They involved thermal action, sympathetic vi-
bration at the skin surface, and immunomodulation.8-10
However, there is lack of scientific basis explaining the
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mechanistic action of a wide range of moxibustion ap-
plications.
Oxidative stress is considered to be an important ele-
ment in the pathogenesis of various conditions includ-
ing inflammation, cancer, and aging, and the antioxi-
dant effects of many therapies and remedies have been
well demonstrated.11,12 Some reports have revealed the
antioxidant property of acupuncture treatment.13-15
Based on traditional theory and clinical applications,
moxibustion is also anticipated to induce antioxidative
activity in the body. However, no clinical investigations
of a connection between moxibustion and antioxidant
effects have been performed.
Therefore, we investigated whether chronic indirect
moxibustion at two acupoints (Guanyuan, CV 4 and
Shenque, CV 8) affects oxidative stress and antioxidant
capacity in healthy adult volunteers.
METHODS
Subjects
Adults considered to be healthy by self-judgment were
recruited, and volunteers showing abnormalities on ra-
diological or hematological examinations were exclud-
ed. A physician and radiologist performed these exami-
nations at Daejeon University Hospital. We also ex-
cluded night workers, alcohol drinkers, smokers, medi-
cation users, and overweight individuals (body mass in-
dex of >30). Of those recruited, 25 subjects (5 men
and 20 women) were included (median age, 47 years;
range, 20-65 years). Informed consent was obtained
from each subject, and the ethical committee of Dae-
jeon University Hospital approved the study protocol
(authorization number: DJOMC-33-1).
Study design and moxibustion treatment
All moxibustion treatments in every subject were per-
formed by a licensed doctor throughout the trial.
Moxibustion was performed on subjects at two acu-
points on the Conception Vessel Meridian: Guanyu-
an (CV 4, located at 3 cun below the center of the
umbilicus) and Shenque (CV 8, located at the center
of the umbilicus) three times per week for 4 weeks.
One moxa corn (3.5 g of wormwood fiber on the
top of salt inside bamboo; diameter, 30 mm; length,
40 mm; KyeGoo Inc., Incheon, Korea) was burned
for 30 min per treatment while the volunteers were
lying on their backs (Figure 1).
To examine the effects of indirect moxibustion on the
status of the antioxidant defense system, lymphocyte
subpopulations and cytokines were evaluated in blood
(serum) samples collected on the day before the first
moxibustion treatment and 1 hour after the final moxi-
bustion under conditions of an 8-h fast.
Chemical materials
1,1,3,3-tetraethoxypropane (TEP), N,N-diethyl-para-
phenylendiamine (DEPPD), ferrous sulfate, trichloro-
aceticacid(TCA),5,5-dihiobis-(2-nitrobenzoicacid)(DT-
NB),potassiumphosphate, reducedglutathione,myoglo-
bin, 2,2¢-azino-bis(3-ethylbenzothiazoline-6-sulfonic
acid) diammonium salt (ABTS), glutathione reductase,
and the reduced form of β-nicotinamide adenine dinu-
cleotide phosphate (β-NADPH) were purchased from
Sigma (St. Louis, MO). Thiobarbituric acid (TBA) was
obtained from Lancaster Co. (Lancashire, England).
Hydrogen peroxide was purchased from Junsei Chemi-
cal Co., Ltd. (Tokyo, Japan). 1-butanol was purchased
from J.T. Baker (Mexico City, Mexico).
Total reactive oxygen species
The total reactive oxygen species (ROS) level in serum
was determined according to the method of Hayashi.16
Briefly, hydrogen peroxide was used to generate a
calibration curve by standard methods. DEPPD
solution and ferrous sulfate solution were prepared
beforehand. A total of 5 mL of standard solution or
serum was added to 140 mL of 0.1 M sodium acetate
buffer (pH 4.8) in each well of 96-well plates and
incubated at 37° C for 5 min. A total of 100 mL of
DEPPD and ferrous mixture solution were added to each
well, and the ROS level was determined at 505 mm
using a spectrophotometer.
Lipid peroxide as malondialdehyde
Lipid peroxide levels in the serum were determined us-
ing thiobarbituric acid-reactive substances (TBARS) as
described by Kamal.17 The concentration of TBARS
was expressed as malondialdehyde (MDA) mM in se-
rum. Briefly, 250 mL of serum or standard solution
was added to 2.5 mL of 20% TCA. It was mixed with
1 mL of 0.67% TBA and heated at 100°C for 30 min,
followed by cooling on ice and vigorous vortexing with
4 mL of n-butanol. After centrifugation at 3000 × g for
20 min, the upper organic layer absorbance was mea-
sured at 535 nm with a spectrophotometer and com-
pared with the TEP standard curve.
Total antioxidant capacity
The total antioxidant capacity (TAC) was determined ac-
cording to the method of Kambsyashi.18 A total of 90 mL
A B
Figure 1 Moxibustion treatment and moxa. Moxibustion
was performed at acupoints CV 4 and CV 8 three times per
week for 4 weeks (A). One moxa comprised 3.5 g of worm-
wood fiber inside a bamboo with a salt base (B).
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of 10 mM phosphate-buffered saline (pH 7.2), 50 mL
of myoglobin solution (45 mM), 20 mL of 3 mM
ABTS solution, 20 mL of diluted serum sample, and
trolox were added to a 96-well microplate and mixed
well at 25°C for 3 min. Next, 20 mL of H2O2 was
added to each well and incubated for 5 min. The ab-
sorbance was read using a plate reader at 600 nm
(Molecular Device Corp., USA). The TAC was ex-
pressed as trolox equivalent antioxidant capacity
(TEAC).
Catalase, superoxide dismutase, and total gluta-
thione
Catalase activity in the serum was determined using
themethod of Beers and Siezer.19 Briefly, 100mL of dilut-
ed serum or standard solution was mixed with 2.9 mL of
substrate solution (0.0036% [w/w] hydrogen peroxide
in 50 mM potassium phosphate), followed by mea-
surement of absorbance at 240 nm after 5 min. Su-
peroxide dismutase (SOD) activity in the serum was
determined using an SOD assay kit (Dojindo Labora-
tories, Kumamoto, Japan) according to the manufac-
turer's protocol. Bovine erythrocyte SOD (Sigma)
was used as a standard.
The total glutathione content was determined accord-
ing to the method of Evans.20 Briefly, 50 mL of diluted
serum (in 10 mM PBS, pH 7.2) or glutathione standard
was combined with 80 mL of DTNB/NADPH mix-
ture (10 mL of 4 mM DTNB and 70 mL of 0.3
mM NADPH) in a 96-well microplate. A total of 20
mL (0.06 U) of glutathione reductase solution was
added to each well, and the absorbance was mea-
sured using a plate reader at 405 nm (Molecular De-
vices, Sunnyvale, CA).
Lymphocyte subpopulations
Complete blood counts including differential white
blood cell counts were analyzed using an auto hemato-
analyzer (Celltack-α, Nihon, Japan). A lymphocyte
subclass analysis of cytotoxic T cells, helper T cells, B
cells, and natural T cells was performed using flow cy-
tometry (BD FACSCaliber, BD Biosciences, USA)
with a Multitest IMK Kit (BD Biosciences, Canada) ac-
cording to the manufacturer's protocol.
Cytokine antibody array
The expression of 42 serum cytokines was examined us-
ing the Human Cytokine Antibody Array III (Ray Bio-
tech, Inc., USA), which contained antibodies against
ENA-78, GCSF, GM-CSF, GRO, GRO-α, I-309,
IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10,
IL-12, p40, p70, IL-13, IL-15, IFN-γ, MCP-1,
MCP-2, MCP-3, MCSF, MDC, MIG, MIP-15, RAN-
TES, SCF, SDF-1, TARC, TGF- β1, TNF-α, TNF-β,
EDF, IGF-I, angiogenin, oncostatin M, thrombopoi-
etin, VEGF, PDGF BB, and leptin. Images were cap-
tured with an image analyzer (Bio-Rad Laboratories,
Segrate, Italy) and analyzed using Quantity One soft-
ware (Bio-Rad Laboratories).
Self-reporting of changes in subjective symptoms
A doctor performed medical examinations in the form
of a questionnaire or handwritten case report form re-
garding specific symptoms before and after the clinical
study. All participants were instructed to report any
subjective feelings or changes in symptoms, including
adverse effects.
Statistical analysis
Statistical comparisons of all biological parameters be-
tween before and after moxibustion were analyzed with a
paired t-test. Statistical significancewas fixed atP<0.05.
RESULTS
Effects of moxibustion on serum ROS, MDA, and
TAC levels
The mean concentration of serum ROS was（136 ±
51）units at the initial time point of moxibustion and
significantly decreased to 101±35 units after 4 weeks of
moxibustion (P<0.01) (Figure 2A).The serumMDA lev-
el also significantly decreased from (6±2) to (4±2) mM
after the moxibustion trial (P<0.01) (Figure 2B).
Meanwhile, the TAC, expressed as TEAC, significantly
increased by about 30% [from (335 ± 74) to (401 ±
33) units] with moxibustion (P<0.01) (Figure 2C).
Change in catalase and SOD activities and total
glutathione content in serum
The serum catalase activity was significantly increased
with 4 weeks of moxibustion from 41±17 to 58±34
units (P<0.05) (Figure 2D). However, no significant
change was observed in SOD activity (from 3.2±0.4 to
3.4±0.4 units) or total glutathione content (from 63±
17 to 58±16 mM) (Figure 2E, F).
Analysis of lymphocyte subpopulations and serum
cytokine profiles
Lymphocyte subpopulations, including cytotoxic T
cells, helper T cells, B cells, and natural killer cells,
were analyzed. No significant changes were observed in
their relative proportions or absolute cell numbers
between peripheral blood samples before and after the
moxibustion trial (Figure 3A, B).
In addition, the semi-quantitative analysis of 42
cytokines showed no significant changes between
serum samples taken before and after the moxibustion
trial (Figure 3C, D).
Improvement in subjective symptoms by
self-reporting
Twelve of 20 female participants reported at least one
subjective symptom or physical feeling in which they
felt improvement after moxibustion. The improved
symptoms included constipation (five subjects), men-
struation or menstrual pain (three subjects), digestion
or appetite (four subjects), fatigue (three subjects), and
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skin condition (one subject). One of five male partici-
pants reported that his hands and feet became warmer
after the trial. One woman subject complained of mild
itching and rubefaction of the skin around the navel.
DISCUSSION
Like acupuncture, moxibustion has been a major thera-
peutic in traditional Oriental medicine. Numerous
studies on the clinical applications of acupuncture and
their corresponding mechanisms have been performed,
but there are very few studies on moxibustion. Moxi-
bustion is generally thought to be preferable as a pre-
ventive therapeutic compared with acupuncture.21
Therefore, we investigated the effect of moxibustion at
CV 4 and CV 8 on the status of the oxidative stress
condition and immune-related parameters in healthy
volunteers. These two acupoints (CV 4, CV 8) have
been used to enhance vital energy in both patients with
pathological disorders and healthy patients.22
We observed that indirect moxibustion at these acu-
points lowered the serum concentration of total ROS
(Figure 2A). ROS are normally produced during cellu-
lar metabolism, but they are also a major contributor
of many diseases through damage of cell structures by
DNA alteration and oxidation of proteins and lipids.23
MDA is a quantitative marker of lipid peroxidation by
ROS, and the serum level of MDA is also significantly
reduced by indirect moxibustion (Figure 2B). These re-
sults were in accordance with the increased TAC (Fig-
ure 2C). Oxidative stressors are normally eliminated by
various antioxidant mechanisms, including free radical
scavengers, catalase, SOD, and the glutathione oxida-
tion/reduction system.24,25 Our results presented signifi-
cantly increased serum levels of catalase activity (Figure
2-D) and no changes in SOD activity or GSH con-
tents (Figure 2E, F).
Several have presented antioxidant action as an impor-
tant mechanism of acupuncture in clinical and animal
experiments.13-15,26 Previous findings confirmed the ele-
vation in SOD and depletion of MDA in a global
brain ischemia rat model.27 Some clinical studies report-
ed the anti-oxidative effects of moxibustion in aged
people.28,29 Other studies have reported its effect on hy-
pertriglyceridemic or hypertensive patients.30,31 Howev-
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Figure 2 Changes in oxidative stress parameters and antioxidant enzymes
Blood was sampled before the trial and after the last moxibustion. The total ROS level (A), MDA level (B), TAC level (expressed as
trolox equivalent antioxidant capacity) (C), catalase activity (D), SOD activity (E), and total glutathione content (F) in serum were
measured. The values are expressed as the mean ± SD; aP<0.05, bP<0.01 between before and after moxibustion using the paired
t-test.
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er, those studies differ from our current study with re-
spect to the experimental model, acupoints, and type
of moxibustion or protocol.
Our results suggest that moxibustion treatment at acu-
points CV 4 and CV 8 has an antioxidative capacity as
evidenced by the significantly decreased ROS and
MDA concentrations and the increased TAC level and
catalase activity after moxibustion. These results could
be indicative of reduced susceptibility to oxidative dam-
age, which is possibly relevant to the preventive effect
of moxibustion therapy. We examined whether repeat-
ed indirect moxibustion influences immunological pa-
rameters, especially in lymphocyte subpopulations and
serum cytokines. The acupoints CV 4 and CV 8 treat-
ed in this study are traditionally believed to help im-
mune function, and two animal studies showed im-
mune-modulating effects such as changes in serum
IL-12 levels and NK cell activities.32,33 However, we ob-
served no significant changes in either analysis of lym-
phocyte subpopulations or 42 cytokines in the periph-
eral blood (Figure 3). For more accurate quantification
of important cytokine candidates, including interfer-
on-gamma and IL-12, we performed analyses using in-
dividual ELISA kits, but no changes were observed (da-
ta not shown). In contrast to our results, one group ob-
served increased helper T cells in healthy women and
increased cytotoxic T cells in women with systemic lu-
pus erythematosus after indirect moxibustion on Zu-
sanli (ST 36) and Sanyinjiao (SP 6) for 1 week.34 These
differences might have been caused by dissimilarities in
experiment designs, such as rodent versus human bod-
ies, pathologic and physiological states, locations of
moxibustion, or direct versus indirect moxibustion.
We did not quantify the improvements in symptoms be-
cause all volunteers were basically healthy. Thirteen par-
ticipants reported that they felt subjectively better at the
end of the trial, which might have been at least partially
linked to the antioxidative action of moxibustion.
Our study includes a key limitation in interpretation of
the results because this study was not based on a ran-
domized controlled trial. It is very difficult to blind
subjects using sham moxibustion treatment.35,36 We
must consider the possibility of biased results in a sin-
gle-arm study. The present study results in healthy sub-
jects may reinforce the application of moxibustion for
the management of human ailments. Taken together,
we can conclude that repeated indirect moxibustion on
CV 4 and CV 8 has antioxidative stress activity in
healthy subjects. Further studies are needed to confirm
this finding in larger-scale trials with a control group.
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Figure 3 Lymphocyte subpopulations and human cytokine array
Blood was collected before the trial and after the last moxibustion. A lymphocyte subclass analysis was performed using the FACS
system (A, B). A total of 42 cytokines in serum were analyzed using the Human Cytokine Antibody Array III (C, D). The cytokines
are listed in the Subjects and Methods section.
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